Search Results - "Burgin, Alex B."

Refine Results
  1. 1

    Resveratrol Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP Phosphodiesterases by Park, Sung-Jun, Ahmad, Faiyaz, Philp, Andrew, Baar, Keith, Williams, Tishan, Luo, Haibin, Ke, Hengming, Rehmann, Holger, Taussig, Ronald, Brown, Alexandra L., Kim, Myung K., Beaven, Michael A., Burgin, Alex B., Manganiello, Vincent, Chung, Jay H.

    Published in Cell (03-02-2012)
    “…Resveratrol, a polyphenol in red wine, has been reported as a calorie restriction mimetic with potential antiaging and antidiabetogenic properties. It is…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    A novel and unified two-metal mechanism for DNA cleavage by type II and IA topoisomerases by Deweese, Joseph E, Osheroff, Neil, Berger, James M, Schmidt, Bryan H, Burgin, Alex B

    Published in Nature (London) (03-06-2010)
    “…Type II topoisomerases are required for the management of DNA tangles and supercoils, and are targets of clinical antibiotics and anti-cancer agents. These…”
    Get full text
    Journal Article
  5. 5

    Structural basis for the design of selective phosphodiesterase 4B inhibitors by Fox, David, Burgin, Alex B., Gurney, Mark E.

    Published in Cellular signalling (01-03-2014)
    “…Phosphodiesterase-4B (PDE4B) regulates the pro-inflammatory Toll Receptor –Tumor Necrosis Factor α (TNFα) pathway in monocytes, macrophages and microglial…”
    Get full text
    Journal Article
  6. 6

    The Mechanism of Topoisomerase I Poisoning by a Camptothecin Analog by Staker, Bart L., Hjerrild, Kathryn, Feese, Michael D., Behnke, Craig A., Burgin, Alex B., Stewart, Lance

    “…We report the x-ray crystal structure of human topoisomerase I covalently joined to double-stranded DNA and bound to the clinically approved anticancer agent…”
    Get full text
    Journal Article
  7. 7

    Artificial neural networks trained to detect viral and phage structural proteins by Seguritan, Victor, Alves, Jr, Nelson, Arnoult, Michael, Raymond, Amy, Lorimer, Don, Burgin, Jr, Alex B, Salamon, Peter, Segall, Anca M

    Published in PLoS computational biology (01-08-2012)
    “…Phages play critical roles in the survival and pathogenicity of their hosts, via lysogenic conversion factors, and in nutrient redistribution, via cell lysis…”
    Get full text
    Journal Article
  8. 8

    Structures of Three Classes of Anticancer Agents Bound to the Human Topoisomerase I−DNA Covalent Complex by Staker, Bart L, Feese, Michael D, Cushman, Mark, Pommier, Yves, Zembower, David, Stewart, Lance, Burgin, Alex B

    Published in Geochimica et cosmochimica acta (07-04-2005)
    “…Human topoisomerase I (top1) is the molecular target of a diverse set of anticancer compounds, including the camptothecins, indolocarbazoles, and…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Structure and function of a cyanophage-encoded peptide deformylase by Frank, Jeremy A, Lorimer, Don, Youle, Merry, Witte, Pam, Craig, Tim, Abendroth, Jan, Rohwer, Forest, Edwards, Robert A, Segall, Anca M, Burgin, Alex B

    Published in The ISME Journal (01-06-2013)
    “…Bacteriophages encode auxiliary metabolic genes that support more efficient phage replication. For example, cyanophages carry several genes to maintain host…”
    Get full text
    Journal Article
  11. 11

    A Maltose-Binding Protein Fusion Construct Yields a Robust Crystallography Platform for MCL1 by Clifton, Matthew C, Dranow, David M, Leed, Alison, Fulroth, Ben, Fairman, James W, Abendroth, Jan, Atkins, Kateri A, Wallace, Ellen, Fan, Dazhong, Xu, Guoping, Ni, Z J, Daniels, Doug, Van Drie, John, Wei, Guo, Burgin, Alex B, Golub, Todd R, Hubbard, Brian K, Serrano-Wu, Michael H

    Published in PloS one (24-04-2015)
    “…Crystallization of a maltose-binding protein MCL1 fusion has yielded a robust crystallography platform that generated the first apo MCL1 crystal structure, as…”
    Get full text
    Journal Article
  12. 12

    A novel norindenoisoquinoline structure reveals a common interfacial inhibitor paradigm for ternary trapping of the topoisomerase I-DNA covalent complex by Marchand, Christophe, Antony, Smitha, Kohn, Kurt W, Cushman, Mark, Ioanoviciu, Alexandra, Staker, Bart L, Burgin, Alex B, Stewart, Lance, Pommier, Yves

    Published in Molecular cancer therapeutics (01-02-2006)
    “…We show that five topoisomerase I inhibitors (two indenoisoquinolines, two camptothecins, and one indolocarbazole) each intercalate between the base pairs…”
    Get full text
    Journal Article
  13. 13

    Mechanisms of Camptothecin Resistance by Human Topoisomerase I Mutations by Chrencik, Jill E, Staker, Bart L, Burgin, Alex B, Pourquier, Philippe, Pommier, Yves, Stewart, Lance, Redinbo, Matthew R

    Published in Applied physics letters (11-06-2004)
    “…Human topoisomerase I relaxes superhelical tension associated with DNA replication, transcription and recombination by reversibly nicking one strand of duplex…”
    Get full text
    Journal Article
  14. 14

    Substrate Specificity of Tyrosyl-DNA Phosphodiesterase I (Tdp1) by Raymond, Amy C., Staker, Bart L., Burgin, Alex B.

    Published in The Journal of biological chemistry (10-06-2005)
    “…Tyrosyl-DNA phosphodiesterase I (Tdp1) hydrolyzes 3′-phosphotyrosyl bonds to generate 3′-phosphate DNA and tyrosine in vitro. Tdp1 is involved in the repair of…”
    Get full text
    Journal Article
  15. 15

    Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety by Burgin, Alex B, Gurney, Mark E, Magnusson, Olafur T, Singh, Jasbir, Witte, Pam, Staker, Bart L, Bjornsson, Jon M, Thorsteinsdottir, Margret, Hrafnsdottir, Sigrun, Hagen, Timothy, Kiselyov, Alex S, Stewart, Lance J

    Published in Nature biotechnology (2010)
    “…Finding safe inhibitors of phosphodiesterase 4, the enzyme that breaks down cAMP, has been a longstanding goal in pharmaceutical development. Burgin et al …”
    Get full text
    Journal Article
  16. 16

    Phosphodiesterase-4 (PDE4) Molecular Pharmacology and Alzheimer’s Disease by Gurney, Mark E., D’Amato, Emily C., Burgin, Alex B.

    Published in Neurotherapeutics (01-01-2015)
    “…Between 20% and 25% of patients diagnosed with Alzheimer’s disease (AD) do not have amyloid burden as assessed by positron emission tomography imaging. Thus,…”
    Get full text
    Journal Article
  17. 17

    Uncoupling the Chemical Steps of Telomere Resolution by ResT by Kobryn, Kerri, Burgin, Alex B., Chaconas, George

    Published in The Journal of biological chemistry (22-07-2005)
    “…ResT is the telomere resolvase of the spirochete Borrelia burgdorferi, the causative agent of Lyme disease. ResT is an essential cellular function that…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Analysis of Human Tyrosyl-DNA Phosphodiesterase I Catalytic Residues by Raymond, Amy C., Rideout, Marc C., Staker, Bart, Hjerrild, Kathryn, Burgin, Alex B.

    Published in Journal of molecular biology (14-05-2004)
    “…Tyrosyl-DNA phosphodiesterase I (Tdp1) is involved in the repair of DNA lesions created by topoisomerase I in vivo. Tdp1 is a member of the phospholipase D…”
    Get full text
    Journal Article
  20. 20

    Substitution of Conserved Residues within the Active Site Alters the Cleavage Religation Equilibrium of DNA Topoisomerase I by Colley, William C., van der Merwe, Marie, Vance, John R., Burgin, Alex B., Bjornsti, Mary-Ann

    Published in The Journal of biological chemistry (24-12-2004)
    “…Eukaryotic DNA topoisomerase I (Top1p) catalyzes the relaxation of supercoiled DNA and constitutes the cellular target of camptothecin (CPT). Mutation of…”
    Get full text
    Journal Article